18 research outputs found

    Portuguese category norms for children

    Get PDF
    This study presents Portuguese category norms for children of three different age groups: preschoolers (3- to 4-year-olds), second graders (7- to 8-year-olds), and preadolescents (11- to 12-year-olds). Three hundred Portuguese children (100 in each group) completed an exemplar-generation task. Preschoolers generated exemplars for 13 categories, second graders generated exemplars for 17 categories, and preadolescents generated exemplars for 21 categories. For each group, responses within each category were organized according to frequency of production in order to derive exemplar-production norms for sets of tested categories. The results also included information about the number of responses and exemplars, idiosyncratic and inappropriate responses, and commonality and diversity indexes for all the categories. A comparison of these children’s norms with the Portuguese adult norms was also presented. The full set of norms may be downloaded from www.psychonomic.org/archive

    Antenatal care in Goroka: issues and perceptions.

    Get PDF

    Notes on Technic

    No full text

    Delineating Terminal Change in Subjective Well-Being and Subjective Health

    No full text
    The present study investigated whether several evaluative indicators of subjective well-being (SWB) and subjective health decline as death approaches and which of them shows a stronger decline. Using three-wave longitudinal data from deceased participants of the Cross-Sectional and Longitudinal Aging Study (N = 1,360; age range 75--94 at T1= Time 1), we found a stronger decline in most evaluative indicators when plotted by distance-to-death relative to distance from birth. After controlling for background characteristics and physical and cognitive functioning, death-related decline was still found for SWB but not for subjective health. Implications are discussed regarding the well-being paradox and the yet unclear mechanisms that link evaluative indicators to the dying process. Copyright 2009, Oxford University Press.

    High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea

    Get PDF
    INTRODUCTION: Papua New Guinea is a Pacific Island nation of 7.3 million people with an estimated HIV prevalence of 0.8%. ART initiation and monitoring are guided by clinical staging and CD4 cell counts, when available. Little is known about levels of transmitted HIV drug resistance in recently infected individuals in Papua New Guinea. METHODS: Surveillance of transmitted HIV drug resistance in a total of 123 individuals recently infected with HIV and aged less than 30 years was implemented in Port Moresby (n = 62) and Mount Hagen (n = 61) during the period May 2013-April 2014. HIV drug resistance testing was performed using dried blood spots. Transmitted HIV drug resistance was defined by the presence of one or more drug resistance mutations as defined by the World Health Organization surveillance drug resistance mutations list. RESULTS: The prevalence of non-nucleoside reverse transcriptase inhibitor transmitted HIV drug resistance was 16.1% (95% CI 8.8%-27.4%) and 8.2% (95% CI 3.2%-18.2%) in Port Moresby and Mount Hagen, respectively. The prevalence of nucleoside reverse transcriptase inhibitor transmitted HIV drug resistance was 3.2% (95% CI 0.2%-11.7%) and 3.3% (95% CI 0.2%-11.8%) in Port Moresby and Mount Hagen, respectively. No protease inhibitor transmitted HIV drug resistance was observed. CONCLUSIONS: The level of non-nucleoside reverse transcriptase inhibitor drug resistance in antiretroviral drug naïve individuals recently infected with HIV in Port Moresby is amongst the highest reported globally. This alarming level of transmitted HIV drug resistance in a young sexually active population threatens to limit the on-going effective use of NNRTIs as a component of first-line ART in Papua New Guinea. To support the choice of nationally recommended first-line antiretroviral therapy, representative surveillance of HIV drug resistance among antiretroviral therapy initiators in Papua New Guinea should be urgently implemented
    corecore